Medicare AdvantageCoverageMedium impact
MA11.112, Composite Tissue Allotransplantation of the Hand(s) and Face
Independence Blue Cross·Transplant Surgery, Plastic Surgery·Medical Policy
Effective date
Jun 24, 2026
We identified it
Jun 25, 2026
Summary
Medicare Advantage policy MA11.112 regarding Composite Tissue Allotransplantation of the Hand(s) and Face has been reissued effective 06/24/2026. This is a specialized transplant policy that establishes coverage criteria and requirements for hand and face composite tissue allograft procedures under MA plans. The billing team must review the full policy details to identify any changes from the previous version and implement updated coverage, prior authorization, or documentation requirements.
Action Required
By 06/24/2026: Billing team and clinical staff must obtain and review the complete MA11.112 policy text from the source URL to identify specific coverage criteria, prior authorization requirements, and billing code specifics. Update billing system rules, prior authorization workflows, and provider encounter documentation as needed to comply with reissued policy terms. Contact transplant surgery providers and case managers to ensure awareness of any new requirements. Flag any differences between the previous and reissued versions to determine if retroactive claim review is necessary. Failure to implement required changes may result in claim denials for composite tissue allotransplantation procedures.